Thurston, Springer, Miller, Herd & Titak, Inc. Sanofi Transaction History
Thurston, Springer, Miller, Herd & Titak, Inc.
- $330 Million
- Q3 2024
A detailed history of Thurston, Springer, Miller, Herd & Titak, Inc. transactions in Sanofi stock. As of the latest transaction made, Thurston, Springer, Miller, Herd & Titak, Inc. holds 173 shares of SNY stock, worth $8,352. This represents 0.0% of its overall portfolio holdings.
Number of Shares
173
Previous 173
-0.0%
Holding current value
$8,352
Previous $8,000
12.5%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding SNY
# of Institutions
820Shares Held
274MCall Options Held
2MPut Options Held
1.9M-
Dodge & Cox San Francisco, CA76.3MShares$3.68 Billion2.67% of portfolio
-
Morgan Stanley New York, NY17.8MShares$858 Million0.08% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.4MShares$645 Million0.32% of portfolio
-
Invesco Ltd. Atlanta, GA11.7MShares$562 Million0.13% of portfolio
-
Bank Of America Corp Charlotte, NC11.6MShares$559 Million0.06% of portfolio
About Sanofi
- Ticker SNY
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,508,100,096
- Market Cap $121B
- Description
- Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...